Nico Jacobi - Search Results

Year	Number of Results
2012	1
2013	1
2015	1
2016	1
2017	2
2020	1
2021	2
2024	0

1

ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology.

Jacobi N, Seeboeck R, Hofmann E, Eger A. Jacobi N, et al. Cancers (Basel). 2017 Apr 12;9(4):33. doi: 10.3390/cancers9040033. Cancers (Basel). 2017. PMID: 28417948 Free PMC article. Review.

2

Effect of cachexia on bone turnover in cancer patients: a case-control study.

Zwickl H, Zwickl-Traxler E, Haushofer A, Seier J, Podar K, Weber M, Hackner K, Jacobi N, Pecherstorfer M, Vallet S. Zwickl H, et al. Among authors: jacobi n. BMC Cancer. 2021 Jun 28;21(1):744. doi: 10.1186/s12885-021-08518-9. BMC Cancer. 2021. PMID: 34182958 Free PMC article.

3

Promoter Methylation of Selected Genes in Non-Small-Cell Lung Cancer Patients and Cell Lines.

Sarne V, Huter S, Braunmueller S, Rakob L, Jacobi N, Kitzwögerer M, Wiesner C, Obrist P, Seeboeck R. Sarne V, et al. Among authors: jacobi n. Int J Mol Sci. 2020 Jun 28;21(13):4595. doi: 10.3390/ijms21134595. Int J Mol Sci. 2020. PMID: 32605217 Free PMC article.

4

Alpha-catulin contributes to drug-resistance of melanoma by activating NF-κB and AP-1.

Kreiseder B, Holper-Schichl YM, Muellauer B, Jacobi N, Pretsch A, Schmid JA, de Martin R, Hundsberger H, Eger A, Wiesner C. Kreiseder B, et al. Among authors: jacobi n. PLoS One. 2015 Mar 20;10(3):e0119402. doi: 10.1371/journal.pone.0119402. eCollection 2015. PLoS One. 2015. PMID: 25793618 Free PMC article.

5

Concentration-Dependent Pro- and Antitumor Activities of Quercetin in Human Melanoma Spheroids: Comparative Analysis of 2D and 3D Cell Culture Models.

Hundsberger H, Stierschneider A, Sarne V, Ripper D, Schimon J, Weitzenböck HP, Schild D, Jacobi N, Eger A, Atzler J, Klein CT, Wiesner C. Hundsberger H, et al. Among authors: jacobi n. Molecules. 2021 Jan 30;26(3):717. doi: 10.3390/molecules26030717. Molecules. 2021. PMID: 33573155 Free PMC article.

6

Organotypic three-dimensional cancer cell cultures mirror drug responses in vivo: lessons learned from the inhibition of EGFR signaling.

Jacobi N, Seeboeck R, Hofmann E, Schweiger H, Smolinska V, Mohr T, Boyer A, Sommergruber W, Lechner P, Pichler-Huebschmann C, Önder K, Hundsberger H, Wiesner C, Eger A. Jacobi N, et al. Oncotarget. 2017 Nov 17;8(64):107423-107440. doi: 10.18632/oncotarget.22475. eCollection 2017 Dec 8. Oncotarget. 2017. PMID: 29296175 Free PMC article.

7

A combined impedance and AlphaLISA-based approach to identify anti-inflammatory and barrier-protective compounds in human endothelium.

Pflüger M, Kapuscik A, Lucas R, Koppensteiner A, Katzlinger M, Jokela J, Eger A, Jacobi N, Wiesner C, Hofmann E, Onder K, Kopecky J, Schütt W, Hundsberger H. Pflüger M, et al. Among authors: jacobi n. J Biomol Screen. 2013 Jan;18(1):67-74. doi: 10.1177/1087057112458316. Epub 2012 Aug 30. J Biomol Screen. 2013. PMID: 22941294

8

The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer.

Hofmann E, Seeboeck R, Jacobi N, Obrist P, Huter S, Klein C, Oender K, Wiesner C, Hundsberger H, Eger A. Hofmann E, et al. Among authors: jacobi n. Biomark Res. 2016 Apr 7;4:8. doi: 10.1186/s40364-016-0062-7. eCollection 2016. Biomark Res. 2016. PMID: 27057311 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year